In this issue:
Odds of disease flares after treatment tapering
Relationship between microbiota community and disease activity
Safety and efficacy of biological agents
Factors contributing to health-related QoL
Complications in SLE pregnancies
Survival and mortality rates of SLE
Autoreactive B cells contribution to SLE
Glucocorticoids combined with hydroxychloroquine
Utilisation of phenotype and genetic risk scores
Anti-Ro antibody titers and CNL
Please login below to download this issue (PDF)